Transplantation Flashcards
1. What is a graft between different members of the same species termed?
A Autograft
B Isograft
C Xenograft
D Allograft
E None of the above
D Allograft
2. Which of the following statements is NOT TRUE? Rejection of a second (set) skin graft from the same allogeneic donor:
A Can be blocked by azathioprine (an antimitotic agent)
B Proceeds at the same speed as the first graft rejection
C Shows specificity for the graft donor
D Can be transferred to a naive recipient with lymphocytes
E Involves recognition of MHC differences
B Proceeds at the same speed as the first graft rejection
3. Which of the following statements is TRUE of the human major histocompatibility complex (MHC)?
A MHC provokes the most intense allograft reactions
B MHC is termed H-2
C MHC contains only class I and class II genes
D MHC is not expressed as codominant antigens on the cell surface
E MHC encodes the human leukocyte antigens (HLA) expressed only on leukocytes
A MHC provokes the most intense allograft reactions
4. Mitosis occurs when mixing lymphocytes of two individuals:
A In presence of mitomycin C
B In presence of anti-CD4
C Who are identical twins
D Of differing MHC class II haplotype
E Of differing MHC class I, but identical MHC class II, haplotype
D Of differing MHC class II haplotype
5. Graft vs host disease occurs on injecting adult T-cells of strain A into:
A F1 (A × B) animals
B Unirradiated strain B
C Irradiated strain A
D Strain A fetuses
E Cultures of lymphocytes from strain B
A F1 (A × B) animals
6. Non-specific suppression of graft rejection can be achieved with:
A Ricin A chain
B Anti-IL-5
C Anti-NFκB
D Anti-CD34
E Anti-CD3
E Anti-CD3
7. What is the target of the monoclonal antibody basiliximab used to help suppress allograft rejection?
A CD3
B CD40L
C LFA-1
D ICAM-1
E CD25
E CD25
8. Why have pigs have been proposed as a source of organs for xenotransplantation to humans?
A They do not pose a risk of zoonoses
B Their cell surface glycoproteins bear galactose α-1,3-galactose structures
C They lack endogenous virus sequences
D Their hearts are an appropriate size and the pigs can be genetically modified to limit the possibility of hyperacute rejection
E Their organs are not susceptible to hyperacute rejection because they become coated with the natural antibodies normally present in humans
D Their hearts are an appropriate size and the pigs can be genetically modified to limit the possibility of hyperacute rejection
9. What is the approximate 1-year survival rate for cadaver kidneys grafted into individuals with no DR mismatches?
A >95%.
B 80–90%
C 55–65%
D 40–50%
E <40%
B 80–90%
10. Graft vs host disease often accompanies transplantation of:
A Cartilage
B Kidney
C Bone marrow
D Heart
E Pancreas
C Bone marrow
11. Which of the following statements is TRUE of HLA-G?
A HLA-G is an MHC class II molecule
B HLA-G is present on extravillous cytotrophoblast
C HLA-G stimulates NK cell-mediated lysis
D HLA-G activates DAF
E HLA-G stimulates IL-10 synthesis
B HLA-G is present on extravillous cytotrophoblast
12. The very rapid response to a second allogeneic graft is:
A Specific for antigens of the major histocompatibility complex (MHC)
B Dependent on minor histocompatibility antigens
C Transferred by macrophages to a naive recipient
D Transferred by platelets
E Transferred by IgA
A Specific for antigens of the major histocompatibility complex (MHC)
13. Concerning MHC class II antigen differences between two individuals, which of the following is NOT TRUE?
A They produce mixed lymphocyte reactions
B They stimulate formation of helpers to generate cytotoxic T-cells
C They cause graft vs host disease
D For sibling pairs, they will only exist on average in one in four cases
E None of the above
D For sibling pairs, they will only exist on average in one in four cases
14. Hyperacute graft rejection is caused by:
A Preformed antibody
B CD4 lymphocytes
C CD8 lymphocytes
D Platelets
E Circulating immune complexes
A Preformed antibody
15. Which of the following does NOT minimize allogeneic graft rejection?
A Cyclosporine
B Disodium cromoglycate
C Azathioprine
D Cross-matching for ABO and MHC
E Anti-CD4
B Disodium cromoglycate